chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills; high fever that is not going down of 104.4; feeling weak; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot number: Not reported), via an unspecified route of administration on an unspecified date as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history was not reported. Concomitant medications were not reported. The patient stated that she had the second part of the COVID vaccine yesterday (date unspecified), and she was experiencing chills and a high fever that was not going down. She stated that her fever was 104.4 (unit not stated). She stated that she was feeling weak and she did not want to complete a report. She just wanted more information on these side effects from the product. The outcome of the events was unknown.  Information about batch/lot number has been requested.  Follow-up attempts are completed. No further information is expected.
Her temp is 101.7 F; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Sep2022 at 19:45 as dose number unknown (booster), single (Lot number: GH9694) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: High blood pressure; "Cholesterol" (unspecified if ongoing), notes: Cholesterol. The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer.), for COVID-19 immunization.  The following information was reported: PYREXIA (non-serious) with onset 09Sep2022, outcome "recovering", described as "Her temp is 101.7 F". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia.
Pt. has no temp. area not reddened, not irritated, not warm to the touch. There is a small area where the needle was inserted, that has a gray to silver particle that is raised, but seems to be intradermal. Mom has not noticed it prior to today. 12/11/09. Area is on Lt deltoid.
After both shots, I had pain in my uterus.  Two days after my first shot, I had a sacral herpes attack while the pelvic/uterus pain persisted. Three days after the second shot, my menstruation started 12 days early. This was a 16 day cycle which has never happened to me. It has started and stopped several times.
Day one- The patient contacted the clinic with complaints of right arm pain and tenderness. The patient was advised by nurse to ice affected arm and to try Tylenol.                                                                                                         Day two- The patient examined due to complaints of severe (10/10) right shoulder pain, significant pain noted on external rotation and the patient is unable to hold her arm at 90 degrees. Diagnosis of bursitis, rotator cuff tendonitis, and capsulitis. Patient was started on Prednisone and Lortab.                                                                Day 6- The patient continues to have right shoulder pain, Celebrex was started.        Day 17- The patient was diagnosed with right bicipital tendonitis. The patient continues to have disability in her right arm. She can not perform her daily activities.
Spontaneously developed full body rash/hives (both itchy and painful) , significant swelling of hands and feet. Spontaneous urticaria began nine days after vaccination, and has improved, but has not gone away, at the time of this report (twenty-eight days after vaccination, nineteen days after symptoms appeared). No other symptoms, such as fever, difficulty breathing, nausea, or stomach pain. No noticeable other potential causes (no change in diet, environment, or other external stimuli). Treated with Zyrtec, Benadryl, hydrocortisone, aloe vera, and advil for the swelling. Swelling went away after approximately one week and has not returned. Rash and hives would respond to medications/ topical treatments, but remained severe for about ten days. Though no longer severe, rash and hives have not yet gone away. No new symptoms have developed.
Kept her in the bed for a week; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) (lot number: AG8347) on unspecified date in 2019 at single dose for immunisation. Medical history and concomitant medications were not reported. She wanted to know this and where the ingredients come from since she had a bad reaction to the drug, she described it as "out of the charts" reaction that kept her in the bed for a week. This all happened back in Oct2019. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
No adverse event; The patient received Moderna first dose on 30-Nov-2022, Moderna second dose on 19-Jan-2023, and the bivalent on 23-Feb-2023; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received Moderna first dose on 30-Nov-2022, Moderna second dose on 19-Jan-2023, and the bivalent on 23-Feb-2023) and NO ADVERSE EVENT (No adverse event) in a 64-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 010H22A) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 23-Feb-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 23-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received Moderna first dose on 30-Nov-2022, Moderna second dose on 19-Jan-2023, and the bivalent on 23-Feb-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received Moderna first dose on 30-Nov-2022, Moderna second dose on 19-Jan-2023, and the bivalent on 23-Feb-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received Moderna first dose on 30-Nov-2022, Moderna second dose on 19-Jan-2023, and the bivalent on 23-Feb-2023).    No concomitant information was reported. Suspect product dosage text was reported as initial booster. It was reported that patient did not report any reaction. It was reported that patient received first dose on 30-Nov-2022 and second dose on 19-Jan-2023. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-713010 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-713010:Monovalent dose
Information has been received from physician concerning a male who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Subsequently the patient experienced thrombocytopenia.  Unspecified medical attention was sought and the patient was hospitalized.  The patient's outcome was recovered.  There was no product quality complaint involved.
I had slight itching after injection while waiting the 15 minutes in the store after injection.  I started next day feeling slight sore throat, then under-the-weather, so unable to work at computer.. fever in evening 99.6.  Took  1 tylenol 500. and went to bed ca 7 p.m.   Slept fitfully, joints hurting: back, neck, ribs, knees, hands.  No sweating.  Slight persistent headache.  Feeling of discomfort in bowels all night (constipation not diarrhea).   Injection site hurts to touch. 30 March 2021, today: slight sore throat, headache, right arm injection site --3" redness and swelling around site.  still slight sore throat.  No temperature (97.5).  Feel
Patient started to get rash, mom thought was hives and treated with Benadryl 6.25mg every 6 hours for 5 doses before taking back to Dr. office.  Hives were not showing improvement with Benadryl and Dr. diagnosed with Erythema Multiforme.  Acyclovir was prescribed and improvement was seen.
This case was reported by a other health professional via call center representative and described the occurrence of neck swelling in a 41-year-old female patient who received FLUARIX QUADRIVALENT (batch number 9PX3H, expiry date 30th June 2017). On 28th September 2016, the patient received FLUARIX QUADRIVALENT 0.5 ml. In September 2016, less than a week after receiving FLUARIX QUADRIVALENT, the patient experienced neck swelling. On an unknown date, the outcome of the neck swelling was recovering/resolving. The reporter considered the neck swelling to be almost certainly related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The patient received the FLUARIX QUADRIVALENT at 14:00 pm and developed swelling near her left lateral neck from her ear to where her neck meets her shoulder. The event was reported on the morning of 30th September 2016, but the exact time and date was unknown.
Moderna vaccine was administered to a patient as a booster dose past the published expiry date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was administered to a patient as a booster dose past the published expiry date) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was administered to a patient as a booster dose past the published expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was administered to a patient as a booster dose past the published expiry date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment drugs were reported no adverse events were reported   This case was linked to MOD-2022-590949 (Patient Link).
I haven't had a period in over 15 years, the next day a gush of blood came out of me with blood clots it was a one-time thing I showered and not a drop of blood came out of me after that I was also having some issues at the time of the shot the next day I felt something in my mouth I went to go spit on a napkin and there was a tiny little blood clots coming from my gums I called Urgent Care they sent me to the lab they called me back and said everything was good with my labs I have an appointment next week for an OBGYN
A week post admin of the vax PT's right eye (upper eyelid) became slightly swollen. He was treated with Benadryl. It resolved after 2.5 days.
Admission Date: 7/30/2022 Discharge Date: 8/1/2022  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: 97-year-old male in his normal state of health presented to the emergency room with weakness.  He also has noted progressive memory issues per the son.  This did seem to go on from last several weeks to months.  He also had a friend who was exposed to that had COVID and was hospitalized.  During hospitalization he did very well.   Hospital course: He was treated for community-acquired pneumonia and did very well. His mental status was back to baseline by the next am. He was evaluated by case management and PT and recommended some PT. Family arranged for him to go to assisted living. He never required treatment for Covid, but I did discuss Paxlovid with the patient and son
Post vax, the pt developed diarrhea and cramping. He also had a fever, nausea and dizziness. He had a ear infection and a head cold.
Pain; small, pea size nodule under skin; induration approx. 3 cm; This case was reported by a nurse via sales rep and described the occurrence of pain in a female patient who received Men B NVS (Bexsero) for prophylaxis.   In May 2019, the patient received Bexsero. On an unknown date, less than a month after receiving Bexsero, the patient experienced pain, injection site induration and injection site nodule. On an unknown date, the outcome of the pain and injection site induration were recovered/resolved and the outcome of the injection site nodule was unknown.   It was unknown if the reporter considered the pain, injection site induration and injection site nodule to be related to Bexsero.  Additional details were provided as follows: This case was reported by the family nurse practitioner (FNP). The patient received Bexsero 3 weeks before on an unknown arm from the date of reporting. The patient had pain that awakened from sleep and induration approximately 3 cm for 2 days. The patient had small pea size nodule under skin. The Patient was planning for 2nd injection on other arm. The reporter agreed to followup from GlaxoSmithKline.
My son had fever the night of 4/14/13 thru the evening of 4/16/13, for about 48 hours, approximately 10 days after the shot was given. He also had a large swelling at the site of the vaccination along with redness.
BODY ACHES; FEVER; EXHAUSTION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, fever, and exhaustion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and fever, and was recovering from exhaustion. This report was non-serious.
2 hours after injection of Shingrix, I had excoriation of lower lip with some tingling. by morning, I have lightly scabbed over lesion on lower lip. Some swelling and sensitivity/numbness of lower lip.
Hives, scratchy throat, shivering, weak, tired, sweating, rash
Swelling, redness, discomfort of entire right upper extremity and extremity was hot to touch.
Pt recvd immun & devel fever of 104 rectally; Pt fine otherwise;
Tongue and right side of face went numb within minutes of receiving in right arm. Continued getting worse. After getting home, I waited 2 hours and took Benadryl and went to bed. Morning still numb but better. Feels like I can?t taste on that side. Also have a headache and just overall feeling lethargic.
Pt recvd 3 doses of Engerix-B on 19MAR91, 7MAY91 & 30SEP91 & devel swollen eyes, tight swollen throat, hives, itching, aching of muscles & became tired; took Hydroxine for itching; sx gone w/in 3 days;
Size of 2 oranges - whole thigh swollen and hot. Benadryl and Motrin, cold packs.
Patient given pediatric Hep B after consult with HD. Patient given adult Hep B vaccine approx 15 minutes after Peds dose. No adverse symptoms noted.
AE began day p/vax diarrhea, fever, h/a, muscle aches;2nd day leg red welts on rt arm lasted 4 days;
Area was red/warm, hard lump. Still has knot now. But pt is doing fine.
Pfizer-BioNTech COVID 19 Vaccine EUA----Hives, itching, rapid heart rate 120-140, rapid breathing, next morning 2/3/21 HA, body aches & nausea. Treatment day of with Benadryl 50mg PO X 2 doses 2 hours apart 2/3/21 Tylenol & Benadryl.
Patient woke up w/ chest pain, continued to have chest pain 3-4 times per week.
pt recvd vax 20APR93 t101.5 ax, reddness of rt leg, mild swelling; reddness & swelling thru Wed; pt limping; pt taken to ER;
At 8:45am, this RN was notified that client beginning to itch after receiving injection. This RN assessed client and she denies any difficulty breathing at this time, but states nose, fingers, hands, and neck are itching. This RN noted hives to L hand, neck, and upper back. Client had received injection in L deltoid at 8:30am. Per protocol, client was given 50mg IM Benadryl. Monitored client x 30 more minutes and at 9:20am client stated itching is completely gone and denies any other s/s. Client encouraged to call 911 of develops distress at home. Client also encouraged to drink plenty of water.  Verbalized understanding.
congestion in ears after 1st and 2nd vaccination. Tinnitus worsened after both doses and has not returned to baseline.
Starting 15 minutes after the injection patient stated that she got a headache.  By 3:45 pm she states she felt, "foggy headed.. I was having difficulty processing thoughts, I felt out of it."  Her daughter came to pick her up and told her her words were slurred.  She went to her home and took Ibuprofen and Benadryl.  She states she was very exhausted. At 8pm she experienced uncontrollable chills.  That night, in the middle of the night she started having a fever of 102 degrees Fahrenheit.  She took ibuprofen and tylenol at this time.  She started experiencing her right leg cramping and twitching.  She states that on 1/29 she continued to have fever and started having stomach cramps and nausea.  On 1/30 She states s
Patient reports arm soreness and neck swelling. Has slight rash by left collarbone. Effects started at some point after vaccine and were still present in afternoon of 5/22/21
Pain, redness, knot under skin, warmth, bruise and temp 100.7.
Sudden oncoming feeling of dizziness, light headedness accompanied by hunger. I began to cook some soup. Within 5 minutes it got much worse and I prepared to vomit in the kitchen sink. It felt like really bad flu symptoms. I then passed out, busted my nose on the kitchen sink, and then hit my head on the floor and got a cut on my shin (from the cabinet most likely). My wife heard the commotion and  came to find me lying passed out in the kitchen floor, just coming to. I remember being in a great slumber, most likely from being knocked out) The contusions weren't severe enough for a hospital visit, but we are both a bit freaked out by the incident. I have never passed out like that before.
Flu vacc on 10/3. 10/4 AM - red, raised area RUE measured 55mmx60mm. 10/5 AM increased in size to 80mm across/60mm down. Sent to see PHCP started on antibiotics for cellulitis slowly improved.
Had chills and fever for 48 hours, but the unusual was the red spot that occurred in the left arm below and to the side of the shot site.  It itched and was  warm to touch.  It is nearly gone now.  Doesn't itch much at all now.
Developed wheezing & cyanosis after receiving immunization chest - markedly diminished breath sounds with wheezing.  HR 120/min. EPINEPHRINE 0.15 mg SQ, DECADRON 9 mg IM, XOPEREX, O2 @ 6 liters O2 sat 98%.  HR 115 @ discharge.  Sent to hospital for observation.
Since the vaccination, has the patient been tested for COVID-19?:Yes; Since the vaccination, has the patient been tested for COVID-19?:Yes; Immediate rapid heart beat and increased blood pressure; Immediate rapid heart beat and increased blood pressure; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 22Jan2021 at 12:00 as dose 1, single (Batch/Lot number: unknown) at the age of 58 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Irritated Bowel" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; CARVEDILOL; SIMVASTATIN. The following information was reported: HEART RATE INCREASED (non-serious), BLOOD PRESSURE INCREASED (non-serious) all with onset 21Jan2022, outcome "recovered" and all described as "Immediate rapid heart beat and increased blood pressure"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 21Jan2022, outcome "unknown" and all described as "Since the vaccination, has the patient been tested for COVID-19?:Yes". The events "immediate rapid heart beat and increased blood pressure" required emergency room visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: (unspecified date) increased; Heart rate irregular: (unspecified date) Immediate rapid heartbeat; SARS-CoV-2 test: (unspecified date) Negative, notes: Covid test type post vaccination: Nasal Swab; (21Jan2022) positive. Therapeutic measures were taken as a result of heart rate increased, blood pressure increased: treatment with fluids. The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
eye lids burned after each shot pretty badly/tears still burn her eyelids pretty significantly; cry; eyes get watery; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07May2021 as dose 2, single (batch/lot number: EW0173) at the age of 55 years, in right arm for covid-19 immunization. The patient's relevant medical history included: "latex allergies" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Albuterol, reactions: "allergies". Vaccination history included: BNT162b2 (dose 1, batch/lot number EW0164, location left arm), administration date: 16Apr2021, when the patient was 55-year-old, for Covid-19 immunization, reactions: "eye lids burned, pretty badly". The following information was reported: EYELID IRRITATION (medically significant), outcome "unknown", described as "eye lids burned after each shot pretty badly/tears still burn her eyelids pretty significantly"; CRYING (non-serious), outcome "unknown", described as "cry"; LACRIMATION INCREASED (non-serious), outcome "unknown", described as "eyes get watery". Clinical course: The patient informed that her eye lids burned after each shot pretty badly. The patient informed that with the first occurrence, they made her sit with the paramedics for a bit. After each subsequent shot, she knew it would pass so did not report. Now, all this time later, every single time she cry or her eyes get watery, her tears still burn her eyelids pretty significantly to the point that she has to wipe them away or it's unbearable.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300247350 same patient/product, different dose;US-PFIZER INC-202300247305 same patient/product, different dose;
About 10 minutes after the vaccine, patient fainted for 20 seconds and afterward felt slightly nauseous and vomited. Patient has history of fainting during vaccination.
IMMEDIATE: dizziness, light-headedness, shortness of breath, jaw clenched shut (lasted about 30 seconds) FOUR HOURS AFTER VACCINATION: muscle weakness, confusion, brain fog (All of these symptoms are on-going.) 33 HOURS AFTER VACCINATION: in addition to previously mentioned symptoms, fever, chills, extreme muscle fatigue, headache, jaw soreness